In this free webinar, learn how cell line selection, process optimization and purification strategies can support reliable, scalable monoclonal antibody manufacturing. The featured speaker will discuss upstream and downstream development, analytical characterization and common approaches such as Protein A chromatography. Attendees will also explore how process robustness, scale-up planning and experienced CDMO support can help prepare mAb programs for clinical and commercial manufacturing.
TORONTO, July 29, 2026 /PRNewswire/ — Monoclonal antibodies (mAbs) are among the most widely used biologic therapies, with applications across oncology, autoimmune disorders and infectious diseases. This webinar explores key manufacturing considerations for reliable, scalable monoclonal antibody production.
Although mAbs are often considered one of the more predictable biologic modalities, successful development still requires careful planning across cell line selection, process optimization, purification, analytical characterization and scale-up. Maintaining product quality, process robustness and manufacturing readiness remains critical from early development through commercial supply.
In this webinar, attendees will gain a practical overview of the key development and manufacturing considerations for monoclonal antibodies. Topics will include cell line development and selection, upstream process optimization, downstream purification strategies and the analytical tools used to characterize product quality. Participants will also learn how standard purification approaches, including Protein A affinity chromatography and additional chromatography and filtration steps, help remove impurities while preserving product integrity.
The session will further explore why monoclonal antibodies are often viewed as one of the most manufacturable biologic modalities. Advances in cell line engineering, process optimization and scalable manufacturing technologies have enabled modern processes to achieve high productivity while supporting efficient clinical and commercial supply. Attendees will also gain insights into scale-up considerations, process robustness and the role experienced CDMO partners play in supporting successful technology transfer, validation and commercialization efforts.
Register for this webinar to learn how biologic modalities such as monoclonal antibodies can be developed and manufactured through reliable, scalable and compliant production strategies.
Join Dave Briggs, PhD, MSAT Principal Scientist, Late Stage/Commercial, Avid Bioservices, for the live webinar on Tuesday, August 18, 2026, at 12pm EDT (6pm CEST / EU-Central).
For more information, or to register for this event, visit Improve Biologic Modalities Manufacturing for mAb Readiness.
ABOUT AVID BIOSERVICES
Avid Bioservices is a leading U.S.-based mammalian cell culture contract development and manufacturing organization (CDMO) providing integrated process development, analytical development, and CGMP biologics manufacturing from DNA to IND to commercial supply. With you, every molecule of the way.
To learn more about Avid Bioservices, visit www.avidbio.com
ABOUT XTALKS
Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.
Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what’s next.
To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/
Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/improve-biologic-modalities-manufacturing-for-mab-readiness-upcoming-webinar-hosted-by-xtalks-302837282.html
SOURCE Xtalks
